{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T05:44:52Z","timestamp":1792820692625,"version":"4.5.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2022,12,24]],"date-time":"2022-12-24T00:00:00Z","timestamp":1671840000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,12,24]],"date-time":"2022-12-24T00:00:00Z","timestamp":1671840000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1007\/s00228-022-03445-5","type":"journal-article","created":{"date-parts":[[2022,12,24]],"date-time":"2022-12-24T04:22:16Z","timestamp":1671855736000},"page":"311-319","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Application of machine learning to predict tacrolimus exposure in liver and kidney transplant patients given the MeltDose formulation"],"prefix":"10.1007","volume":"79","author":[{"given":"Laure","family":"Ponthier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Marquet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk Jan A. R.","family":"Moes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lionel","family":"Rostaing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bart","family":"van Hoek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Monchaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Labriffe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1695-0695","authenticated-orcid":false,"given":"Jean Baptiste","family":"Woillard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,12,24]]},"reference":[{"key":"3445_CR1","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1097\/FTD.0000000000000640","volume":"41","author":"M Brunet","year":"2019","unstructured":"Brunet M, van Gelder T, \u00c5sberg A, Haufroid V, Hesselink DA, Langman L et al (2019) Therapeutic drug monitoring of tacrolimus-personalized therapy: second consensus report. Ther Drug Monit 41:261\u2013307","journal-title":"Ther Drug Monit"},{"key":"3445_CR2","doi-asserted-by":"crossref","unstructured":"Woillard JB, Monchaud C, Saint-Marcoux F, Labriffe M, Marquet P (2022) Can the area under the curve\/trough level ratio be used to optimize tacrolimus individual dose adjustment? Transplantation. Volume-Issue-10.1097","DOI":"10.1097\/TP.0000000000004405"},{"key":"3445_CR3","doi-asserted-by":"publisher","first-page":"623","DOI":"10.2165\/00003088-200443100-00001","volume":"43","author":"CE Staatz","year":"2004","unstructured":"Staatz CE, Tett SE (2004) Clinical pharmacokinetics and pharmacodynamics of tacrolimus in solid organ transplantation. Clin Pharmacokinet 43:623\u2013653","journal-title":"Clin Pharmacokinet"},{"key":"3445_CR4","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/s40262-013-0120-3","volume":"53","author":"DA Hesselink","year":"2014","unstructured":"Hesselink DA, Bouamar R, Elens L, van Schaik RHN, van Gelder T (2014) The role of pharmacogenetics in the disposition of and response to tacrolimus in solid organ transplantation. Clin Pharmacokinet 53:123\u2013139","journal-title":"Clin Pharmacokinet"},{"key":"3445_CR5","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1097\/FTD.0b013e318285e779","volume":"35","author":"F Saint-Marcoux","year":"2013","unstructured":"Saint-Marcoux F, Woillard J-B, Jurado C, Marquet P (2013) Lessons from routine dose adjustment of tacrolimus in renal transplant patients based on global exposure. Ther Drug Monit 35:322\u2013327","journal-title":"Ther Drug Monit"},{"key":"3445_CR6","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.phrs.2018.02.016","volume":"130","author":"J-B Woillard","year":"2018","unstructured":"Woillard J-B, Saint-Marcoux F, Debord J, \u00c5sberg A (2018) Pharmacokinetic models to assist the prescriber in choosing the best tacrolimus dose. Pharmacol Res 130:316\u2013321","journal-title":"Pharmacol Res"},{"key":"3445_CR7","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1111\/ajt.12191","volume":"13","author":"R Bouamar","year":"2013","unstructured":"Bouamar R, Shuker N, Hesselink DA, Weimar W, Ekberg H, Kaplan B et al (2013) Tacrolimus predose concentrations do not predict the risk of acute rejection after renal transplantation: a pooled analysis from three randomized-controlled clinical trials. Am J Transplant 13:1253\u20131261","journal-title":"Am J Transplant"},{"key":"3445_CR8","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1007\/s40262-017-0533-5","volume":"56","author":"J-B Woillard","year":"2017","unstructured":"Woillard J-B, Debord J, Monchaud C, Saint-Marcoux F, Marquet P (2017) Population pharmacokinetics and Bayesian estimators for refined dose adjustment of a new tacrolimus formulation in kidney and liver transplant patients. Clin Pharmacokinet 56:1491\u20131498","journal-title":"Clin Pharmacokinet"},{"key":"3445_CR9","doi-asserted-by":"crossref","unstructured":"Martial LC, Biewenga M, Ruijter BN, Keizer R, Swen JJ, van Hoek B et al (2021) Population pharmacokinetics and genetics of oral meltdose tacrolimus (Envarsus) in stable adult liver transplant recipients. Br J Clin Pharmacol 87:4262\u20134272.","DOI":"10.1111\/bcp.14842"},{"key":"3445_CR10","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1517\/17460441.2016.1146250","volume":"11","author":"AN Lima","year":"2016","unstructured":"Lima AN, Philot EA, Trossini GHG, Scott LPB, Maltarollo VG, Honorio KM (2016) Use of machine learning approaches for novel drug discovery. Expert Opin Drug Discov 11:225\u2013239","journal-title":"Expert Opin Drug Discov"},{"key":"3445_CR11","doi-asserted-by":"crossref","unstructured":"Woillard J-B, Labriffe M, Debord J, Marquet P (2020) Tacrolimus Exposure prediction using machine learning. Clin Pharmacol Ther 110:361\u2013369","DOI":"10.1002\/cpt.2123"},{"key":"3445_CR12","doi-asserted-by":"crossref","unstructured":"Denney WS, Duvvuri S, Buckeridge C (2015) Simple, automatic noncompartmental analysis: the PKNCA R package. J Pharmacokinet Pharmacodyn. [cited 2021 May 9];42:11\u2013107. Available from: http:\/\/link.springer.com\/10.1007\/s10928-015-9432-2. Accessed 17 Mar 2022","DOI":"10.1007\/s10928-015-9432-2"},{"key":"3445_CR13","unstructured":"Kuhn M, Wickham H (2020). Tidymodels: a collection of packages for modeling and machine learning using tidyverse principles. https:\/\/www.tidymodels.org. Accessed 17 Mar 2022"},{"key":"#cr-split#-3445_CR14.1","doi-asserted-by":"crossref","unstructured":"Chen T, Guestrin C (2016) XGBoost: A scalable tree boosting system. Proceedings of the 22nd ACM SIGKDD International Conference on Knowledge Discovery and Data Mining. San Francisco California USA: ACM","DOI":"10.1145\/2939672.2939785"},{"key":"#cr-split#-3445_CR14.2","unstructured":"[cited 2021 Jun 30]. p. 785-94. Available from: https:\/\/dl.acm.org\/doi\/10.1145\/2939672.2939785. Accessed 17 Mar 2022"},{"key":"3445_CR15","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1177\/096228029500400303","volume":"4","author":"JH Friedman","year":"1995","unstructured":"Friedman JH, Roosen CB (1995) An introduction to multivariate adaptive regression splines. Stat Methods Med Res 4:197\u2013217","journal-title":"Stat Methods Med Res"},{"key":"3445_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v033.i01","volume":"33","author":"J Friedman","year":"2010","unstructured":"Friedman J, Hastie T, Tibshirani R (2010) Regularization paths for generalized linear models via coordinate descent. J Stat Softw 33:1\u201322","journal-title":"J Stat Softw"},{"key":"3445_CR17","doi-asserted-by":"publisher","first-page":"462430","DOI":"10.1016\/j.chroma.2021.462430","volume":"1653","author":"S Deprez","year":"2021","unstructured":"Deprez S, Stove CP (2021) Fully automated dried blood spot extraction coupled to liquid chromatography-tandem mass spectrometry for therapeutic drug monitoring of immunosuppressants. J Chromatogr A 1653:462430","journal-title":"J Chromatogr A"},{"key":"3445_CR18","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1097\/FTD.0000000000000643","volume":"41","author":"S Capiau","year":"2019","unstructured":"Capiau S, Veenhof H, Koster RA, Bergqvist Y, Boettcher M, Halmingh O et al (2019) Official International Association for Therapeutic Drug Monitoring and Clinical Toxicology guideline: development and validation of dried blood spot-based methods for therapeutic drug monitoring. Ther Drug Monit 41:409\u2013430","journal-title":"Ther Drug Monit"},{"key":"3445_CR19","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1097\/FTD.0000000000000893","volume":"43","author":"L Delahaye","year":"2021","unstructured":"Delahaye L, Veenhof H, Koch BCP, Alffenaar J-WC, Linden R, Stove C (2021) Alternative sampling devices to collect dried blood microsamples: state-of-the-art. Ther Drug Monit 43:310\u201321","journal-title":"Ther Drug Monit"},{"key":"3445_CR20","doi-asserted-by":"publisher","first-page":"105578","DOI":"10.1016\/j.phrs.2021.105578","volume":"167","author":"J-B Woillard","year":"2021","unstructured":"Woillard J-B, Labriffe M, Pr\u00e9maud A, Marquet P (2021) Estimation of drug exposure by machine learning based on simulations from published pharmacokinetic models: the example of tacrolimus. Pharmacol Res 167:105578","journal-title":"Pharmacol Res"},{"key":"3445_CR21","doi-asserted-by":"crossref","unstructured":"Labriffe M, Woillard J-B, Debord J, Marquet P (2022) Machine learning algorithms to estimate everolimus exposure trained on simulated and patient pharmacokinetic profiles. CPT Pharmacometrics Syst Pharmacol 11:1018\u20131028","DOI":"10.1002\/psp4.12810"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-022-03445-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00228-022-03445-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-022-03445-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,26]],"date-time":"2023-01-26T08:05:30Z","timestamp":1674720330000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00228-022-03445-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,24]]},"references-count":22,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,2]]}},"alternative-id":["3445"],"URL":"https:\/\/doi.org\/10.1007\/s00228-022-03445-5","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"value":"0031-6970","type":"print"},{"value":"1432-1041","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,24]]},"assertion":[{"value":"4 October 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 December 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 December 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The trials complied with the Declaration of Helsinki amended in Tokyo, and all the patients enrolled gave their written informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Laure Ponthier, Dirk Jan A.R. Moes, Bart van Hoek, Caroline Monchaud, and Marc Labriffe have no conflicts of interest that are relevant to the content of this manuscript. Pierre Marquet and L Rostaing has received research grants and speaker fees from Chiesi, and JB Woillard has received speaker fees from Chiesi.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}